Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

Toby Kent of AbbVie UK highlights how the forthcoming NHS 10-year plan is a crucial opportunity to set out a vision for ...

The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced ...

The global Oral proteins and peptides market is projected to reach USD 7.38 billion in 2024 will increase to USD 20.36 billion by 2029, with ...

Valuation metrics show AbbVie to be only slightly undervalued based on FY 2025 projections. Read why I'm neutral on ABBV ...